iX Biopharma Ltd announced that it allotted and issued 2,774,778 new ordinary shares on Jul, 17 2026 following the exercise of warrants at an exercise price of 0.06 Singapore dollars per share.

The company’s issued share capital has risen to 1,091,953,119 shares from 1,089,178,341 shares.

The newly issued shares will rank pari passu with existing shares and are expected to begin trading on the Singapore Exchange on or around Jul, 21 2026.

All outstanding warrants expired at 5:00 p.m. on Jul, 17 2026. In total, 57,138,410 warrants—representing 99.35% of the warrants previously issued—were exercised. Of these, 1,362,355 warrants were exercised through valid notices that are still being processed, with the resulting shares to be issued in due course.

Any unexercised warrants have lapsed and are now void.